Biotech entity
Every one of those 1 sits in a single category, funding. Tamara Swaab is most often covered alongside Donald Trump, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 5 original sources each against 2.5 for the same window.
Last mentioned: Aug 1, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Tamara Swaab is most often covered alongside Donald Trump, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 5 original sources each against 2.5 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.7. We currently track 1 Biotech story that mention Tamara Swaab, all published on August 1, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tamara Swaab. Shared-story counts are live from our verified record — not editorial picks.
Biotech and pharma firms face a growing brain drain as three top U.S. cognitive scientists relocate to the U.K. amid NIH and NSF funding upheavals. A survey shows 75% of scientists are considering leaving, threatening the talent pipeline for drug discovery and clinical research.
Tamara Swaab is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
